Nausea and Vomiting Clinical Trials

12 recruiting

Nausea and Vomiting Trials at a Glance

34 actively recruiting trials for nausea and vomiting are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Phase 2 with 8 trials, with the heaviest enrollment activity in Hangzhou, Ankara, and Ankara. Lead sponsors running nausea and vomiting studies include Second Affiliated Hospital, School of Medicine, Zhejiang University, Chongqing University Cancer Hospital, and Centre hospitalier de l'Université de Montréal (CHUM).

Browse nausea and vomiting trials by phase

Treatments under study

About Nausea and Vomiting Clinical Trials

Looking for clinical trials for Nausea and Vomiting? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Nausea and Vomiting trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Nausea and Vomiting clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 34 trials

Recruiting
Phase 2

Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery

AnesthesiaSpinal FusionNausea and Vomiting, Postoperative
IWK Health Centre100 enrolled1 locationNCT06357234
Recruiting
Not Applicable

Dexmedetomidine and Propofol for Sedation in Cataract Surgery.

Nausea and VomitingDexmedetomidineSedation+7 more
Saint-Joseph University1,000 enrolled1 locationNCT07556133
Recruiting
Phase 3

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

ObesityNausea and Vomiting
Vanda Pharmaceuticals280 enrolled10 locationsNCT07446439
Recruiting
Phase 2

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan

Nausea and Vomiting Caused by Trastuzumab Deruxtecan
Second Affiliated Hospital, School of Medicine, Zhejiang University25 enrolled1 locationNCT07537673
Recruiting
Phase 2

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel

Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University25 enrolled1 locationNCT07537660
Recruiting
Phase 2

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide

Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University25 enrolled1 locationNCT07537699
Recruiting
Not Applicable

The Effect of Paedfusor TCI, Eleveld TCI, and Sevoflurane Anesthesia on Postoperative Awakening Agitation in Pediatric Patients

Emergence Delirium in Pediatric AnesthesiaPediatric AnesthesiaPostoperative Nausea and Vomiting (PONV)+1 more
Marmara University Pendik Training and Research Hospital150 enrolled2 locationsNCT07534956
Recruiting
Phase 3

Domperidone in Treating Patients With Gastrointestinal Disorders

Nausea and VomitingGastroparesisDyspepsia+4 more
M.D. Anderson Cancer Center200 enrolled1 locationNCT01696734
Recruiting
Phase 2

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Nausea and Vomiting Chemotherapy-InducedNausea Post Chemotherapy
Helsinn Healthcare SA95 enrolled20 locationsNCT06904235
Recruiting

Quality Improvement Project to Reduce Preoperative Fasting Times Before Elective Procedures

Preoperative FastingPostoperative Nausea and Vomiting (PONV)Perioperative Patient Comfort / Quality of Care
University of Giessen1,000 enrolled1 locationNCT07488468
Recruiting
Not Applicable

Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section

Postoperative IleusCesarean SectionPostoperative Nausea and Vomiting (PONV)+2 more
Nigde Omer Halisdemir University160 enrolled1 locationNCT07440667
Recruiting
Not Applicable

Vomiting Prevention in Children With Cancer

Quality of Life (QOL)Pediatric CancerChemotherapy Induced Nausea and Vomiting
The Hospital for Sick Children1,332 enrolled1 locationNCT06886451
Recruiting
Phase 3

Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients

PreventionNausea and Vomiting, Postoperative
Centre hospitalier de l'Université de Montréal (CHUM)260 enrolled1 locationNCT07248280
Recruiting

Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

Nausea and VomitingOlanzapineSolid Tumours
Shandong Cancer Hospital and Institute2,000 enrolled1 locationNCT07403370
Recruiting
Not Applicable

Brain-Stomach Circuits in Chronic Nausea

Chronic Nausea and Vomiting Syndrome
David Levinthal219 enrolled1 locationNCT07276035
Recruiting
Not Applicable

Thumbtack Needle in the Treatment of NVP

Nausea and Vomiting in Pregnancy (NVP)
Dongmei Huang320 enrolled13 locationsNCT06566274
Recruiting
Phase 4

Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy

Pediatric CancerRadiotherapy-induced Nausea and Vomiting (RINV)
Chongqing University Cancer Hospital60 enrolled1 locationNCT07217600
Recruiting

Inflammatory Biomarkers as Predictors of PONV Following Pediatric Orchiopexy

Pediatric AnesthesiaPostoperative Nausea and Vomiting (PONV)Inflammatory Biomarkers
Diskapi Yildirim Beyazit Education and Research Hospital170 enrolled1 locationNCT07148063
Recruiting
Phase 2Phase 3

Antiemetic Fosaprepitant To Remedy Nausea and Vomiting

Nausea and VomitingVomitingNausea
Montefiore Medical Center250 enrolled1 locationNCT06382012
Recruiting
Phase 4

Oliceridine on Postoperative Nausea and Vomiting in Gynecological Laparoscopic Surgery

Gynecologic Surgical ProceduresPostoperative Nausea and Vomiting (PONV)
YanYing Xiao96 enrolled1 locationNCT07026162